Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
crispr
life sciences
mammoth biosciences
medical devices
national blog main
national top stories
san francisco blog main
san francisco top stories
startups
abbvie
acceleron pharma
acid sphingomyelinase deficiency
allergan
alphabet
alzheimer's disease
anika therapeutics
annovis bio
arcutis biotherapeutics
baricitinib
beam therapeutics
bill & melinda gates foundation
biofourmis
biointellisense
biotechnology industry organization
black diamond therapeutics
boehringer ingelheim
boulder/denver blog main
boulder/denver top stories
broad institute of harvard and mit
brook byers
bruce goldsmith
cancer
cancer drug
charles chu
chronic kidney disease
chronic rhinosinusitis
clinical trials
What
bio
2
×
mammoth
2
×
available
based
big
biosciences
black
cas
cheaper
companies
continue
crispr
debut
develop
diagnostics
diamond
diamond’s
expects
faster
indication
leading
life
march
moves
ohana’s
pop
roundup
science
set
steady
street
therapeutics
things
tiny
today
wall
week
what’s
Language
unset
Current search:
mammoth
×
bio
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14